Nanora’s polymeric nano-delivery system is designed to enable targeted gene silencing,
overcoming the limitations of conventional treatments. Our system is:
a gene that is overexpressed in 17 different
cancer types.
including direct injection and
intranasal delivery.
with minimal toxicity.
supporting commercialization efforts.
How siRNA Works
Pharmaceutical R&D, Cancer Therapy & Brain-Targeted Delivery Solutions
We develop targated hydrogel nanoparticle-based therapeutics for oncology, inflammatory diseases, and neurodegeneration. Our work focuses on cancer management and therapy solutions, optimizing drug bioavailability, and improving treatment specificity.Additionally, we are pioneering brain-targeted delivery systems for brain cancers and Alzheimer’s disease. Our nanocarriers are engineered to cross the blood-brain barrier, ensuring targeted treatment with enhanced efficacy.
We design next-generation siRNA, RNAi, and precision therapeutics to optimize targeted cancer treatment strategies.
Conducting in vitro and in vivo studies to assess drug pharmacokinetics, efficacy, and biocompatibility.
Working with biotechnology firms, research institutions, and pharmaceutical companies to advance nanomedicine innovations.
Providing educational resources, therapy support, and personalized interventions for patients receiving advanced treatments.
“Disclaimer:
This website is intended exclusively for accredited investors who have been directly contacted by our team. The information provided on this site is speculative and forward-thinking, reflecting our vision for the future once Nora HNC 1000 is approved. At present, the products and statements discussed have not been clinically tested or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory body. This site is not a solicitation for investment, and access is restricted to those who have been invited to view
Nanora Bioscience Corporation, based in California, is at the forefront of developing, manufacturing, and commercializing innovative siRNA-based cancer therapeutics. Our mission is to leverage cutting-edge technology to target cancer cells, aiming to inhibit tumor growth and transform cancer treatment with patient-focused solutions.
